Determination of the muscarinic agent [(3-(3-1-butylthio)-1,2,5-thiadiazol-4-yl)-1-azabicyclo[2.2.2]octane], in rat, rabbit, and monkey plasma, using high-performance liquid chromatography in conjunction with tandem mass spectrometry
スポンサーリンク
概要
- 論文の詳細を見る
- 1995-11-03
著者
-
Gillespie Todd
Lilly Research Laboratories Eli Lilly And Company Lilly Corporate Center
-
Gillespie Todd
Lilly Research Laboratories Department Of Drug Metabolism And Disposition
-
Shipley Lisa
Lilly Research Laboratories Eli Lilly And Company Lilly Corporate Center
-
Shipley Lisa
Lilly Research Laboratories Eli Lilly And Company
-
CORNPROPST J.
Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center
-
Cornpropst J.
Lilly Research Laboratories Eli Lilly And Company Lilly Corporate Center
関連論文
- Analysis of olanzapine in human plasma utilizing reversed-phase high-performance liquid chromatography with electrochemical detection
- Determination of xanomeline (LY246708 tartrate), an investigational agent for the treatment of Alzheimer's disease, in rat and monkey plasma by capillary gas chromatography with nitrogen-phosphorus detection
- Determination of the muscarinic agent [(3-(3-1-butylthio)-1,2,5-thiadiazol-4-yl)-1-azabicyclo[2.2.2]octane], in rat, rabbit, and monkey plasma, using high-performance liquid chromatography in conjunction with tandem mass spectrometry